JPMorgan upgrades Tronox stock rating to neutral on valuation
JPMorgan upgraded Tronox (TROX) from Underweight to Neutral, citing challenging demand and rising costs. The stock is near its 52-week low at $2.51, down 71% in six months. JPMorgan withdrew its 2027 price target due to uncertain conditions. Tronox reported a wider-than-expected Q3 2026 loss and lower revenue, but saw year-over-year revenue and EBITDA growth. Negative free cash flow is projected for 2026 and 2027.
How this was made
The 30-second read
Why it matters
The analyst's neutral rating and withdrawal of the price target reinforce a bearish outlook, likely keeping the stock near its 52‑week low.
Market read
The upgrade is a fresh analyst action that may influence short‑term trading decisions on TROX.
What to watch
Potential upside from any future cost‑reduction initiatives or recovery in demand for titanium dioxide.
Background
Tronox is a leading producer of titanium dioxide, a pigment used in paints and coatings. The company has struggled with high input costs and weak demand.
Ticker impact
JPMorgan upgraded Tronox (NYSE:TROX) from Underweight to Neutral, citing weak demand and rising costs, and withdrew its 2027 price target.
likely pressure as the market prices in the neutral stance and ongoing cost challenges
Analyst upgrade with detailed negative outlook and withdrawn target provides fresh, material information that can affect short‑term pricing.
Market effects
Highlights pressure on the titanium dioxide sector from higher raw material costs and weak demand.
U.S. chemical manufacturers may face similar cost headwinds, potentially affecting peer valuations.
Limited to specialty chemicals; no broad market impact.
Counterpoint
Despite the downgrade, the stock may be undervalued given its low price relative to long‑term assets.
Key entities
- AnalystJPMorgan
Provided the upgrade and detailed cost outlook.
- CompanyTronox
Titanium dioxide producer facing cost pressures.
